How Genzyme came to its unique focus on orphan drugs?
Genzyme Corporation had a humble beginning as it was founded by a small number of scientists who were devoted to researching diseases that were genetically inherited. Some years after Genzyme was founded, the Orphan Drug Act was passed into law in the 1980s by countries such as the U.S., Japan, Australia, Canada, and Russia. Such countries intended to encourage developments in drug research, diagnostics, and vaccines that would help improve the treatment options for such rare diseases (Pryde & Groft, 2014). Luckily, this legislation provided various tax exemptions and breaks on costs of Orphan drugs. Notably, an orphan drug is ...